Kyntra Bio, Inc. (KYNB)
7.50
+0.02
(+0.27%)
USD |
NASDAQ |
Feb 13, 16:00
7.50
0.00 (0.00%)
After-Hours: 20:00
Kyntra Bio Free Cash Flow : -17.14M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 825.79M |
| Imunon, Inc. | -14.95M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.847M |
| Cash from Investing (Quarterly) | 87.16M |
| Cash from Financing (Quarterly) | -85.92M |
| Free Cash Flow Per Share (Quarterly) | -0.459 |
| Free Cash Flow to Equity (Quarterly) | 70.24M |
| Free Cash Flow to Firm (Quarterly) | 0.227M |
| Free Cash Flow Yield | -8.08% |